Why the study?
Do plasma BNP and ANF levels correlate with acute cardiac allograft rejection in transplant patients?
Do plasma BNP and ANF levels correlate with acute cardiac allograft rejection in transplant patients?
Plasma BNP levels selectively increase during acute cardiac allograft rejection and may serve as a noninvasive screening test to predict rejection.
No takes yet. Share an insight, caveat, or question.
May support BNP monitoring for rejection surveillance in heart transplant recipients; hypothesis-generating from a single case report, needs prospective validation.
Masters et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: